| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/27/2001 | WO2001098355A2 Cgi-69 compositions and methods of use |
| 12/27/2001 | WO2001098354A2 Human receptors |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098351A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098350A2 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 12/27/2001 | WO2001098339A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/27/2001 | WO2001098338A2 Fluorescent proteins |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098318A1 Haplotypes of the slc26a2 gene |
| 12/27/2001 | WO2001098316A2 Haplotypes of the chrne gene |
| 12/27/2001 | WO2001098315A2 Haplotypes of the hmgcl gene |
| 12/27/2001 | WO2001097868A1 The inactivation of nucleic acids using broad-spectrum pulsed light |
| 12/27/2001 | WO2001097854A2 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics |
| 12/27/2001 | WO2001097847A1 Icp27-binding polynucleotides |
| 12/27/2001 | WO2001097843A2 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | WO2001097616A1 Protein expression profiling |
| 12/27/2001 | WO2001097608A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods |
| 12/27/2001 | WO2001078894A9 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 12/27/2001 | WO2001073111A3 Cell-free reconstitution of autophagocytosis |
| 12/27/2001 | WO2001068901A3 Implantable analyte sensor |
| 12/27/2001 | WO2001058338A3 A method for detecting bacterial exacerbations of chronic lung disease |
| 12/27/2001 | WO2001055310A3 Nucleic acids, proteins, and antibodies |
| 12/27/2001 | WO2001053525A3 Cell isolation method |
| 12/27/2001 | WO2001053505A3 Herpes virus strains for gene therapy |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | WO2001046256A3 Vesicle trafficking proteins |
| 12/27/2001 | WO2001046214A3 Compound comprising a nucleic acid moiety and an organo-silane moiety |
| 12/27/2001 | WO2001044467A3 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 12/27/2001 | WO2001042503A3 Apparatus and methods for drug screening based on nucleic acid analysis |
| 12/27/2001 | WO2001042497A3 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 12/27/2001 | WO2001042496A3 A method of assessing the amount of nucleic acid in a sample |
| 12/27/2001 | WO2001042488A3 Plasminogen activator assay involving an elastase inhibitor |
| 12/27/2001 | WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 12/27/2001 | WO2001038490A3 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 12/27/2001 | WO2001036672A3 Method for detecting pcr products, pcr detection kit and device to be used in such a method |
| 12/27/2001 | WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 12/27/2001 | WO2001031057A3 Double-strand nucleic acid probes and the use thereof |
| 12/27/2001 | WO2001027330A3 Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes |
| 12/27/2001 | WO2001027321A3 Method for detecting differences in gene expression of wild type plants and genetically modified plants |
| 12/27/2001 | US20010056582 Paired mutations |
| 12/27/2001 | US20010056581 Vectors and methods for the mutagenesis of mammalian genes |
| 12/27/2001 | US20010055816 Urinary trypsin inhibitor assay containing a chelating agent |
| 12/27/2001 | US20010055811 Ir maldi mass spectrometry of nucleic acids using liquid matrices |
| 12/27/2001 | US20010055792 Suppression of lysis generation of nucleotide sequences; mix nucleotides and templates, incubate with polymerase and associated enzymes, recover nucleotide sequences |
| 12/27/2001 | US20010055791 Methods for enhancing the production of interferon in cell culture |
| 12/27/2001 | US20010055788 Recombinant bacterial phytases and uses thereof |
| 12/27/2001 | US20010055787 Agar medium for the growth of Mycobacterium tuberculosis |
| 12/27/2001 | US20010055786 Screening method for the discovery and directed evolution of oxygenase enzymes |
| 12/27/2001 | US20010055785 Method of detecting procarboxypeptidase A and carboxypeptidase A levels in biological fluids |
| 12/27/2001 | US20010055782 Enzymatic protein for use in the diagnosis, treatment and prevention of alzheimer's disease and nervous system disorders |
| 12/27/2001 | US20010055780 Bacteriophage coupling to enzyme |
| 12/27/2001 | US20010055773 Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
| 12/27/2001 | US20010055772 Pressure-controlled nucleic acid hybridization |
| 12/27/2001 | US20010055771 Exploiting genomics in the search for new drugs |
| 12/27/2001 | US20010055770 Diagnosing preferential genetic disorder; amplify polymorphic nucleotide sequences from tumor, amplify polymorphic nucleotide sequences from human, compare and evaluate for genetic disorder |
| 12/27/2001 | US20010055769 Method of determining biological/molecular age |
| 12/27/2001 | US20010055768 Multilayer; transparent support, thin metal film and intercalation compound containing nucleic acids |
| 12/27/2001 | US20010055767 Nucleotide sequences coding preferential polypeptides; for use as a diagnostic tool cellular analysis |
| 12/27/2001 | US20010055766 Immunosorbant assay using branched bis-biotin/avidin/multiple label complex as a detection reagent |
| 12/27/2001 | US20010055763 Detecting preferential particles in sample; label particles with lanthanide compounds and detect labeled particles by spectral emission |
| 12/27/2001 | US20010055762 Carrier for immobilizing biologically active substance |
| 12/27/2001 | US20010055760 Oligonucleotides for use as diagnostic tools in drug screening and genetic engineering; antitumor agents |
| 12/27/2001 | US20010055759 Serotype-specific probes for listeria monocytogenes |
| 12/27/2001 | US20010055758 Reagents and methods useful for detecting diseases of the prostate |
| 12/27/2001 | US20010055755 Dendritic marker-expressing macrophage cultures and methods for reactivating latent HCMV |
| 12/27/2001 | US20010055753 Method to regulate CD40 signaling |
| 12/27/2001 | US20010055752 Predictive assay for immune response |
| 12/27/2001 | US20010055634 Process for producing bread |
| 12/27/2001 | US20010055629 Extraction |
| 12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
| 12/27/2001 | US20010054778 Microfabricated elastomeric valve and pump systems |
| 12/27/2001 | US20010054580 Multiplex flow assays preferably with magnetic particles as solid phase |
| 12/27/2001 | CA2635452A1 Looped probe design to control hybridization stringency |
| 12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | CA2414102A1 Universal collection medium |
| 12/27/2001 | CA2414065A1 Cgi-69 compositions and methods of use |
| 12/27/2001 | CA2414062A1 Frozen tissue microarrays and methods for using the same |
| 12/27/2001 | CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | CA2414015A1 Human receptors |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413870A1 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 12/27/2001 | CA2413526A1 Micro-organisms active in the digestive environment |
| 12/27/2001 | CA2413502A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 12/27/2001 | CA2413451A1 Methods of identifying gabab receptor subtype-specific agonists |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2412942A1 Nucleic acid sequences and methods for the modification of plant gene expression |
| 12/27/2001 | CA2412840A1 The inactivation of nucleic acids using broad-spectrum pulsed light |
| 12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | CA2412513A1 Modulators of recombination and methods for producing and using the same |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412110A1 Osteolevin gene polymorphisms |
| 12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | CA2411971A1 Proteases |
| 12/27/2001 | CA2411838A1 Protein expression profiling |
| 12/27/2001 | CA2411834A1 Enzyme detection and measurement |